COLLINS, Michael,KANIA, Robert,KUMPF, Robert,KUNG, Pei-Pei,RICHTER, Daniel,SUTTON, Scott,WYTHES, Martin
申请号：
ES15730290
公开号：
ES2721031T3
申请日:
2015.06.05
申请国别(地区):
ES
年份:
2019
代理人:
摘要：
in which R1, R2, R3, R4, L, X and Z are as defined herein, and the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer.
